{"id":"https://openalex.org/W4376611200","doi":"https://doi.org/10.1158/1078-0432.22820179","title":"Figure S2 from PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer","display_name":"Figure S2 from PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer","publication_year":2023,"publication_date":"2023-05-15","ids":{"openalex":"https://openalex.org/W4376611200","doi":"https://doi.org/10.1158/1078-0432.22820179"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22820179","doi":"https://doi.org/10.1158/1078-0432.22820179","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22820179","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22820179","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009799791","display_name":"Santosh Gupta","orcid":"https://orcid.org/0000-0002-5294-8245","observed_orcids":["https://orcid.org/0000-0002-5294-8245"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Santosh Gupta","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5294-8245","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053535513","display_name":"Susan Halabi","orcid":"https://orcid.org/0000-0003-4135-2777","observed_orcids":["https://orcid.org/0000-0003-4135-2777"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan Halabi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4135-2777","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043904334","display_name":"Qian Yang","orcid":"https://orcid.org/0000-0002-8102-288X","observed_orcids":["https://orcid.org/0000-0002-8102-288X","https://orcid.org/0000-0001-5519-1092"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qian Yang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8102-288X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059932966","display_name":"Akash Roy","orcid":"https://orcid.org/0000-0001-6506-6156","observed_orcids":["https://orcid.org/0000-0001-6506-6156"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akash Roy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6506-6156","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084178911","display_name":"Alisa Tubbs","orcid":"https://orcid.org/0000-0003-1392-2736","observed_orcids":["https://orcid.org/0000-0003-1392-2736"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alisa Tubbs","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1392-2736","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089038984","display_name":"Yamini Gore","orcid":"https://orcid.org/0000-0002-7872-0572","observed_orcids":["https://orcid.org/0000-0002-7872-0572"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yamini Gore","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7872-0572","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020223699","display_name":"Daniel J. George","orcid":"https://orcid.org/0000-0003-1499-7203","observed_orcids":["https://orcid.org/0000-0003-1499-7203","https://orcid.org/0000-0002-0836-8542"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. George","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1499-7203","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028538472","display_name":"David M. Nanus","orcid":"https://orcid.org/0000-0003-3514-2976","observed_orcids":["https://orcid.org/0000-0003-3514-2976"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M. Nanus","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3514-2976","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018645768","display_name":"Emmanuel S. Antonarakis","orcid":"https://orcid.org/0000-0003-0031-9655","observed_orcids":["https://orcid.org/0000-0003-0031-9655","https://orcid.org/0000-0003-3531-3851"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emmanuel S. Antonarakis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0031-9655","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036310901","display_name":"Daniel Costin Danila","orcid":"https://orcid.org/0000-0002-7647-0741","observed_orcids":["https://orcid.org/0000-0002-7647-0741"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel C. Danila","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7647-0741","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078252133","display_name":"Russell Zelig Szmulewitz","orcid":"https://orcid.org/0000-0002-1444-3617","observed_orcids":["https://orcid.org/0000-0002-1444-3617"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Russell Z. Szmulewitz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1444-3617","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044051696","display_name":"RICHARD J. WENSTRUP","orcid":"https://orcid.org/0000-0002-8378-7886","observed_orcids":["https://orcid.org/0000-0002-8378-7886"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Wenstrup","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8378-7886","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5038489185","display_name":"Andrew J. Armstrong","orcid":"https://orcid.org/0000-0001-7012-1754","observed_orcids":["https://orcid.org/0000-0001-7012-1754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew J. Armstrong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7012-1754","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.9200000166893005},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9010000228881836},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.9900000095367432},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":1.0},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9819999933242798},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/ctc-enumeration","display_name":"CTC enumeration","score":0.6489999890327454},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.5239999890327454},{"id":"https://openalex.org/keywords/kaplan-meier-curves","display_name":"Kaplan-Meier curves","score":0.6869999766349792},{"id":"https://openalex.org/keywords/hazard-ratio","display_name":"hazard ratio","score":0.4399999976158142},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5680000185966492},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.6039999723434448},{"id":"https://openalex.org/keywords/ctc-heterogeneity","display_name":"CTC heterogeneity","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7803450226783752},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7652873992919922},{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.6554542779922485},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5655128955841064},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.563934326171875},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.5425134897232056},{"id":"https://openalex.org/C66882249","wikidata":"https://www.wikidata.org/wiki/Q169336","display_name":"Homogeneous","level":2,"score":0.5068410038948059},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4824686348438263},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.4248013198375702},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.41649624705314636},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.41464489698410034},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.35012274980545044},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29651957750320435},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.26510554552078247},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.16218090057373047},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.11481019854545593},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.0},{"id":"https://openalex.org/C97355855","wikidata":"https://www.wikidata.org/wiki/Q11473","display_name":"Thermodynamics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22820179","doi":"https://doi.org/10.1158/1078-0432.22820179","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22820179","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22820179.v1","doi":"https://doi.org/10.1158/1078-0432.22820179.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22820179.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22820179","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Figure_S2_from_PSMA-positive_Circulating_Tumor_Cell_Detection_and_Outcomes_with_Abiraterone_or_Enzalutamide_Treatment_in_Men_with_Metastatic_Castrate-resistant_Prostate_Cancer/22820179","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22820179","doi":"https://doi.org/10.1158/1078-0432.22820179","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22820179","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4365139190","https://openalex.org/W4323809276","https://openalex.org/W4361942618","https://openalex.org/W4376611212","https://openalex.org/W4361879464","https://openalex.org/W4376611291","https://openalex.org/W4376617222","https://openalex.org/W4376611190"],"abstract_inverted_index":{"Kaplan":[0],"Meier":[1],"plots":[2],"depict":[3],"the":[4,31],"association":[5],"between":[6],"PSMA+":[7,17,53,98,114,121,156,163],"CTC":[8,18,115,157],"enumeration":[9,19],"and":[10,12,24,51,66,81,96,119,133,146,161],"OS":[11,38],"PFS.":[13],"The":[14,36,105],"associations":[15],"of":[16],"with":[20],"overall":[21],"survival":[22,26],"(OS)":[23],"progression-free":[25],"(PFS)":[27],"were":[28,57,124],"explored":[29],"using":[30],"proportional":[32],"hazard":[33,71],"model.":[34],"A)":[35],"median":[37,106],"in":[39],"months":[40],"for":[41,87,108,152],"CTC=0":[42,109],"(reference),":[43,110],"CTC+":[44,46,52,90,92,97,113,120,155,162],"PSMA-CTC,":[45,89,112,154],"PSMA+CTC":[47],"but":[48,93,116,158],"heterogeneous":[49,94,117,159],"(<100%),":[50,95,118,160],"100%":[54,99,164],"(homogeneous),":[55],"respectively,":[56,123],"25.7":[58],"(95%":[59,62,64,68,76,79,126,129,131,135,141,144],"CI=19.8-NR),":[60],"24.5":[61],"CI=16.7-30.4),15.6":[63],"CI=14.4-20.7),":[65],"35.0":[67],"CI=16.9-NA).":[69],"Univariate":[70,137],"ratio":[72],"(HR)":[73],"was":[74,139],"1.3":[75],"CI=0.7-2.6),":[77],"2.0":[78,143],"CI=1.0-3.8)":[80],"0.7;":[82],"95%":[83,148],"CI":[84,149],"=":[85,150],"0.2-2.1":[86],"CTC+,":[88,111,153],"PSMA":[91],"(homogeneous)":[100,165],"vs.":[101,166],"CTC=0,":[102,167],"respectively.":[103,168],"B)":[104],"PFS":[107],"100%,":[122],"7.6":[125],"CI=6.7-16.5),":[127],"6.0":[128],"CI=3.5-11.4),5.5":[130],"CI=3.6-7.6),":[132],"5.7":[134],"CI=3.0-NA).":[136],"HR":[138],"1.4":[140],"CI=0.8-2.6),":[142],"CI=1.1-3.6)":[145],"1.5;":[147],"0.7-3.6":[151]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-05-17T00:00:00"}